Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neucardin in Chronic Systolic Heart Failure
NCT03388593Phase 3Recruiting
- Sponsor
- Zensun
- Start
- Jul 2018
- Primary completion
- Feb 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in chronic systolic heart failure (HFrEF), sponsored by Zensun. Started Jul 2018; status: recruiting.
02
Drugs
neucardin
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT03388593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388593.